“Long-term efficacy of omalizumab in patients with conventional treatment-resistant vernal keratoconjunctivitis”, Rev Alerg Mex, vol. 65, no. 2, pp. 192–196, Jul. 2018, doi: 10.29262/ram.v65i2.292.